Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 1733  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Free radical toxicity and antioxidants in Parkinson’s disease

Sudha K, Rao A, Rao S, Rao A

Year : 2003| Volume: 51| Issue : 1 | Page no: 60-62

   This article has been cited by
 
1 Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinsonęs disease
FernƔndez, M. and Barcia, E. and FernƔndez-Carballido, A. and Garcia, L. and Slowing, K. and Negro, S.
International Journal of Pharmaceutics. 2012; 438(1-2): 266-278
[Pubmed]  [Google Scholar]
2 Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of parkinsonęs disease
Koppula, S. and Kumar, H. and More, S.V. and Lim, H.-W. and Hong, S.-M. and Choi, D.-K.
Molecules. 2012; 17(10): 11391-11420
[Pubmed]  [Google Scholar]
3 Nutraceuticals and their preventive or potential therapeutic value in Parkinsonęs disease
Chao, J. and Leung, Y. and Wang, M. and Chang, R.C.-C.
Nutrition Reviews. 2012; 70(7): 373-386
[Pubmed]  [Google Scholar]
4 In vitro antioxidant and anti-arthritic activities of Shilajit
Rege, A. and Juvekar, P. and Juvekar, A.
International Journal of Pharmacy and Pharmaceutical Sciences. 2012; 4(2): 650-653
[Pubmed]  [Google Scholar]
5 Protein oxidation: A potential cause of hypoalbuminemia in oral cancer
Chandran, V. and Anitha, M. and Avinash, S.S. and Rao, G.M. and Shetty, B.V. and Sudha, K.
Biomedical Research. 2012; 23(2): 227-230
[Pubmed]  [Google Scholar]
6 An effective novel delivery strategy of rasagiline for Parkinsonęs disease
FernƔndez, M. and Negro, S. and Slowing, K. and FernƔndez-Carballido, A. and Barcia, E.
International Journal of Pharmaceutics. 2011; 419(1-2): 271-280
[Pubmed]  [Google Scholar]
7 Peripheral markers for oxidative stress in Parkinsonęs disease patients of Eastern India
Sanyal, J. and Sarkar, B. and Banerjee, T.K. and Mukherjee, S.C. and Ray, B.C. and Rao, V.R.
Neurochemical Journal. 2011; 5(2): 146-149
[Pubmed]  [Google Scholar]
8 Influence of ionizing radiation and conventional food processing treatments on the status of free radicals in lotus seeds: An ESR study
Bhat, R. and Sridhar, K.R.
Journal of Food Composition and Analysis. 2011; 24(4-5): 563-567
[Pubmed]  [Google Scholar]
9 Study of telomere length and different markers of oxidative stress in patients with Parkinsonęs disease
Watfa, G. and Dragonas, C. and Brosche, T. and Dittrich, R. and Sieber, C.C. and Alecu, C. and Benetos, A. and Nzietchueng, R.
Journal of Nutrition, Health and Aging. 2011; 15(4): 277-281
[Pubmed]  [Google Scholar]
10 Effects of structural analogues of nociceptin(1-13)NH 2 on brain antioxidant status in kainic acid-treated rats
Tzvetanova, E. and Nenkova, G. and Georgieva, A. and Alexandrova, A. and Girchev, R. and Kirkova, M.
Cell Biochemistry and Function. 2011; 29(2): 135-141
[Pubmed]  [Google Scholar]
11 Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: A short review
Torsdottir, G. and Kristinsson, J. and Snaedal, J. and SveinbjƶrnsdĆ³ttir, S. and Gudmundsson, G. and Hreidarsson, S. and JĆ³hannesson, T.
Journal of the Neurological Sciences. 2010; 299(1-2): 51-54
[Pubmed]  [Google Scholar]
12 The role of oxidative stress in amyotrophic lateral sclerosis and Parkinsonęs disease
Baillet, A. and Chanteperdrix, V. and TrocmƩ, C. and Casez, P. and Garrel, C. and Besson, G.
Neurochemical Research. 2010; 35(10): 1530-1537
[Pubmed]  [Google Scholar]
13 Synthesis and evaluation of antioxidant activities of some indole-2,3-dione derivatives and analogs
Prakash, C.R. and Panneerselvam, T. and Raja, S.
Toxicological and Environmental Chemistry. 2010; 92(8): 1397-1407
[Pubmed]  [Google Scholar]
14 Plasma levels of lipid peroxides in patients with Parkinsonęs disease
Sanyal, J., Bandyopadhyay, S.K., Banerjee, T.K., Mukherjee, S.C., Chakraborty, D.P., Ray, B.C., Rao, V.R.
European Review for Medical and Pharmacological Sciences. 2009; 13(2): 1-2
[Pubmed]  [Google Scholar]
15 Synthesis of some N-substituted nitroimidazole derivatives as potential antioxidant and antifungal agents
Olender, D., Zwawiak, J., Lukianchuk, V., Lesyk, R., Kropacz, A., Fojutowski, A., Zaprutko, L.
European Journal of Medicinal Chemistry. 2009; 44(2): 1-2
[Pubmed]  [Google Scholar]
16 Study of the cytotoxicity and antioxidant capacity of N/OFQ(1-13)NH 2 and its structural analogues
Kirkova, M., Zamfirova, R., Leśkiewicz, M., Kubera, M., Lasoń, W., Todorov, S.
Pharmacological Reports. 2009; 61(6): 1-2
[Pubmed]  [Google Scholar]
17 Are nociceptin(1-13)NH2 and its structural analogue [ORN9]nociceptin(1-13)NH2 able to affect brain antioxidant status in control and kainic acid-treated rats?
Tzvetanova, E., Pavlova, A., Alexandrova, A., Nenkova, G., Petrov, L., Kirkova, M., Girchev, R., Naydenova, E.
Cell Biochemistry and Function. 2009; 27(4): 1-2
[Pubmed]  [Google Scholar]
18 Determination of an antioxidant capacity index by immobilized tyrosinase bioreactor
Girelli, A.M., Giuliani, T., Mattei, E., Papaleo, D.
Journal of Agricultural and Food Chemistry. 2009; 57(12): 1-2
[Pubmed]  [Google Scholar]
19 Antioxidant supplements in management of Parkinsonęs disease
Ribarova, F., Stoimenova, A., Popova, K.
Archives of the Balkan Medical Union. 2009; 44(2): 1-2
[Pubmed]  [Google Scholar]
20 Increased oxidative damage in peripheral blood correlates with severity of Parkinsonęs disease
Chen, C.-M., Liu, J.-L., Wu, Y.-R., Chen, Y.-C., Cheng, H.-S., Cheng, M.-L., Chiu, D.T.-y.
Neurobiology of Disease. 2009; 33(3): 1-2
[Pubmed]  [Google Scholar]
21 Effect of resistance training on blood oxidative stress in Parkinson disease
Bloomer, R.J., Schilling, B.K., Karlage, R.E., Ledoux, M.S., Pfeiffer, R.F., Callegari, J.
Medicine and Science in Sports and Exercise. 2008; 40(8): 1-2
[Pubmed]  [Google Scholar]
22 Statin adverse effects: A review of the literature and evidence for a mitochondrial mechanism
Golomb, B.A., Evans, M.A.
American Journal of Cardiovascular Drugs. 2008; 8(6): 1-2
[Pubmed]  [Google Scholar]
23 Immunomodulatory and antioxidant activity of a polyherbal formulation
Meera, S., Gupta Atyam, V.S.S.S., Kumar, N.S.
International Journal of Pharmacology. 2008; 4(4): 1-2
[Pubmed]  [Google Scholar]
24 Oxidative stress mediated electrolyte imbalance in Parkinsonęs disease
Saxena, R., Jaiswal, G., Lal, A.M., Sarkar, S.
Biomedicine. 2008; 28(1): 1-2
[Pubmed]  [Google Scholar]
25 Peripheral blood markers of oxidative stress in Parkinsonęs disease
Younes-Mhenni, S., Frih-Ayed, M., Kerkeni, A., Bost, M., Chazot, G.
European Neurology. 2007; 58(2): 78-83
[Pubmed]  [Google Scholar]
26 Advances in the treatment of Parkinsonęs disease
Singh, N., Pillay, V., Choonara, Y.E.
Progress in Neurobiology. 2007; 81(1): 29-44
[Pubmed]  [Google Scholar]
27 Evaluation of Pluchea carolinensis extracts as antioxidants by the epinephrine oxidation method
Evaluation of Pluchea carolinensis extracts as antioxidants by the epinephrine oxidation method
Fitoterapia. 2006; 77(3): 221-226
[Pubmed]  [Google Scholar]
28 Reactive intermediates and the pathogenesis of adverse drug reactions: The toxicology perspective
Amacher, D.E.
Current Drug Metabolism. 2006; 7(3): 219-229
[Pubmed]  [Google Scholar]
29 Ceruloplasmin and superoxide dismutase (SOD1) in Parkinsonęs disease: A follow-up study
Tórsdóttir, G., Sveinbjörnsdóttir, S., Kristinsson, J., Snaedal, J., Jóhannesson, T.
Journal of the Neurological Sciences. 2006; 241(1-2): 53-58
[Pubmed]  [Google Scholar]
30 Total antioxidant activity in Parkinsonęs disease
Adiga, U., DęSouza, J., Kousalya, R., Rao, G.M., Nandini, M., DęSouza, V.
Biomedical Research. 2006; 17(2): 145-147
[Pubmed]  [Google Scholar]
31 Neuroprotection by crocetin in a hemi-parkinsonian rat model
Ahmad, A.S., Ansari, M.A., Ahmad, M., Saleem, S., Yousuf, S., Hoda, Md.N., Islam, F.
Pharmacology Biochemistry and Behavior. 2005; 81(4): 805-813
[Pubmed]  [Google Scholar]
32 Kynurenine metabolism in plasma and in red blood cells in Parkinsonęs disease
Hartai, Z., Klivenyi, P., Janaky, T., Penke, B., Dux, L., Vecsei, L.
Journal of the Neurological Sciences. 2005; 239(1): 31-35
[Pubmed]  [Google Scholar]
33 Erythrocyte antioxidant enzymes in Parkinsonęs disease
Abraham, S., Soundararajan, C.C., Vivekanandhan, S., Behari, M.
Indian Journal of Medical Research. 2005; 121(2): 111-115
[Pubmed]  [Google Scholar]
34 Oxidative damage and plasma antioxidants in cerebrovascular accident
Sudha, K., Rao, A.V., Rao, S.N., Rao, A.
Indian Journal of Physiology and Pharmacology. 2004; 48(4): 489-492
[Pubmed]  [Google Scholar]

 

Online since 20th March '04
Published by Wolters Kluwer - Medknow